181 related articles for article (PubMed ID: 24059337)
1. Prion chemical biology: on the road to therapeutics?
Chen B; Thompson M; Louth J; Guo K
Curr Top Med Chem; 2013; 13(19):2441-64. PubMed ID: 24059337
[TBL] [Abstract][Full Text] [Related]
2. Modulation of prion by small molecules: from monovalent to bivalent and multivalent ligands.
Staderini M; Legname G; Bolognesi ML; Menéndez JC
Curr Top Med Chem; 2013; 13(19):2491-503. PubMed ID: 24059331
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a class of diketopiperazines as antiprion compounds.
Bolognesi ML; Ai Tran HN; Staderini M; Monaco A; López-Cobeñas A; Bongarzone S; Biarnés X; López-Alvarado P; Cabezas N; Caramelli M; Carloni P; Menéndez JC; Legname G
ChemMedChem; 2010 Aug; 5(8):1324-34. PubMed ID: 20540064
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship of indole-3-glyoxylamide libraries possessing highly potent activity in a cell line model of prion disease.
Thompson MJ; Borsenberger V; Louth JC; Judd KE; Chen B
J Med Chem; 2009 Dec; 52(23):7503-11. PubMed ID: 19842664
[TBL] [Abstract][Full Text] [Related]
5. SPR biosensor as a tool for screening prion protein binders as potential antiprion leads.
Chen B
Methods Mol Biol; 2010; 627():147-55. PubMed ID: 20217619
[TBL] [Abstract][Full Text] [Related]
6. Strain specificity and drug resistance in anti-prion therapy.
Miller-Vedam L; Ghaemmaghami S
Curr Top Med Chem; 2013; 13(19):2397-406. PubMed ID: 24059341
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a focused library of pyridine dicarbonitriles against prion disease.
Guo K; Mutter R; Heal W; Reddy TR; Cope H; Pratt S; Thompson MJ; Chen B
Eur J Med Chem; 2008 Jan; 43(1):93-106. PubMed ID: 17475368
[TBL] [Abstract][Full Text] [Related]
8. Rational targeting for prion therapeutics.
Mallucci G; Collinge J
Nat Rev Neurosci; 2005 Jan; 6(1):23-34. PubMed ID: 15611724
[TBL] [Abstract][Full Text] [Related]
9. The transmissible spongiform encephalopathies of livestock.
Greenlee JJ; Greenlee MH
ILAR J; 2015; 56(1):7-25. PubMed ID: 25991695
[TBL] [Abstract][Full Text] [Related]
10. Animal models for testing anti-prion drugs.
Fernández-Borges N; Elezgarai SR; Eraña H; Castilla J
Curr Top Med Chem; 2013; 13(19):2504-21. PubMed ID: 24059334
[TBL] [Abstract][Full Text] [Related]
11. The pathogenic mechanisms of prion diseases.
Hur K; Kim JI; Choi SI; Choi EK; Carp RI; Kim YS
Mech Ageing Dev; 2002 Nov; 123(12):1637-47. PubMed ID: 12470901
[TBL] [Abstract][Full Text] [Related]
12. New approaches for the selection and evaluation of anti-prion organic compounds.
Cordeiro Y; Ferreira NC
Mini Rev Med Chem; 2015; 15(2):84-92. PubMed ID: 25723455
[TBL] [Abstract][Full Text] [Related]
13. Prions: protein aggregation and infectious diseases.
Aguzzi A; Calella AM
Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
[TBL] [Abstract][Full Text] [Related]
14. Identifying Anti-prion Chemical Compounds Using a Newly Established Yeast High-Throughput Screening System.
Du Z; Valtierra S; Cardona LR; Dunne SF; Luan CH; Li L
Cell Chem Biol; 2019 Dec; 26(12):1664-1680.e4. PubMed ID: 31668517
[TBL] [Abstract][Full Text] [Related]
15. Antiprion drugs as chemical tools to uncover mechanisms of prion propagation.
Tribouillard D; Gug F; Galons H; Bach S; Saupe SJ; Blondel M
Prion; 2007; 1(1):48-52. PubMed ID: 19164923
[TBL] [Abstract][Full Text] [Related]
16. Altering prion replication for therapy and diagnosis of transmissible spongiform encephalopathies.
Soto C
Biochem Soc Trans; 2002 Aug; 30(4):569-74. PubMed ID: 12196139
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapeutic agents for transmissible spongiform encephalopathies: a review.
Koster T; Singh K; Zimmermann M; Gruys E
J Vet Pharmacol Ther; 2003 Oct; 26(5):315-26. PubMed ID: 14633183
[TBL] [Abstract][Full Text] [Related]
18. Toward Therapy of Human Prion Diseases.
Aguzzi A; Lakkaraju AKK; Frontzek K
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():331-351. PubMed ID: 28961066
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and the prion protein in transmissible spongiform encephalopathies.
Milhavet O; Lehmann S
Brain Res Brain Res Rev; 2002 Feb; 38(3):328-39. PubMed ID: 11890980
[TBL] [Abstract][Full Text] [Related]
20. Prion protein interconversions.
Caughey B
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
